STIM Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally...

Stats
Šios dienos apimtis	30 335.00
Vidutinė apimtis	164 293
Rinkos kapitalizacija	104.15M
EPS	$0 ( 2024-03-05 )
Kita pelno data	( $-0.330 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.33
ATR14	$0.0150 (0.42%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-29	Macan William Andrew	Buy	15 000	Common Stock
2024-02-28	Macan William Andrew	Sell	22 377	Common Stock
2024-02-29	Macan William Andrew	Sell	6 026	Common Stock
2024-02-29	Furlong Stephen	Buy	15 000	Common Stock
2024-02-27	Furlong Stephen	Sell	21 272	Common Stock

INSIDER POWER
17.43
Last 100 transactions
Buy: 1 892 506 \| Sell: 1 430 741

Tūris Koreliacija

Ilgas: 0.19 (neutral)

Trumpas: 0.17 (neutral)

Signal:(67.02) Neutral

Neuronetics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
AMRB	0.956
MDRX	0.913
FGFPP	0.908
NETE	0.908
MMAC	0.907
LWAC	0.901
XEL	0.897
UTHR	0.888
LNT	0.885
RVSB	0.884

10 Labiausiai neigiamai susiję koreliacijos
SVAC	-0.929
PAYO	-0.904
TLGT	-0.902
PRVA	-0.886
PAIC	-0.885
MRUS	-0.88
WAVD	-0.875
MTSL	-0.868
XPER	-0.868
RMRM	-0.866

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Neuronetics Inc Koreliacija - Valiuta/Žaliavos

0.09
( neutral )

0.24
( neutral )

-0.74
( moderate negative )

-0.06
( neutral )

-0.23
( neutral )

0.37
( neutral )

Neuronetics Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$71.35M
Bruto pelnas:	$49.70M (69.66 %)
EPS:	$-1.050

FY	2023
Pajamos:	$71.35M
Bruto pelnas:	$49.70M (69.66 %)
EPS:	$-1.050

FY	2022
Pajamos:	$65.21M
Bruto pelnas:	$49.72M (76.26 %)
EPS:	$-1.460

FY	2021
Pajamos:	$55.31M
Bruto pelnas:	$43.66M (78.93 %)
EPS:	$-1.186

Financial Reports:

No articles found.

Neuronetics Inc

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Realaus laiko atnaujinimai Neuronetics Inc [STIM]

Upcoming Earnings Alert